Table 2. Clinical characteristics of glioblastoma patients (n=76).
Variables | n (%) |
---|---|
Age (years) | |
<50 | 26 (34.2) |
≥50 | 50 (65.8) |
Sex | |
Male | 49 (64.5) |
Female | 27 (35.5) |
Extent of surgery | |
Biopsy | 8 (10.5) |
Subtotal resection | 32 (42.1) |
Gross total resection | 36 (47.4) |
RPA class | |
III | 19 (25.0) |
IV | 42 (55.3) |
V | 15 (19.7) |
Methylation status of MGMT gene promoter | |
Methylated | 47 (61.8) |
Unmethylated | 29 (38.2) |
Postoperative adjuvant therapy | |
Nitrosurea-based combination chemotherapy | 33 (43.4) |
Concurrent chemoradiotherapy with temozolomide | 43 (56.6) |
MGMT, O6-methyl guanine DNA methyltransferase; RPA, recursive partitioning analysis